Targeted binding agents directed to cd105 and uses thereof

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2737667

The invention relates to targeted binding agents against CD105 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to CD105. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of CD105 and as diagnostics.

L'invention concerne des agents de liaison ciblés contre CD105 et l'utilisation de tels agents. De manière plus spécifique, l'invention concerne des anticorps monoclonaux totalement humains dirigés contre CD105. Les agents de liaison ciblés décrits sont utiles dans le traitement de maladies associées à l'activité et/ou la surproduction de CD105 et en tant qu'agents de diagnostic.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Targeted binding agents directed to cd105 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeted binding agents directed to cd105 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted binding agents directed to cd105 and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1899199

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.